Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Ask POZ is an ongoing section on POZ.com dedicated to answering general wellness questions.
Another vaccine, from Novavax, was 89% effective in a U.K. trial, but both were less potent against the South African coronavirus mutation.
A slow vaccine rollout and the emergence of new coronavirus mutations threaten progress in reducing new cases and death.
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
Pfizer/BioNTech’s coronavirus vaccine is 95% effective for preventing symptomatic illness.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
Four vaccine candidates produced antibody and T-cell immune responses in the first stages of human clinical trials.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
Stop me if you’ve heard this one before.
This may help explain why HIV-positive individuals have a harder time quitting cigarettes than those who don’t have the virus.
ViiV alleges that the bictegravir component of the tablet infringes on its own patent for Tivicay (dolutegravir).
“Bicillin is the only treatment for pregnant women with syphilis, and Pfizer has the exclusive patent.”
The sale includes an HIV attachment inhibitor called fostemsavir and a maturation inhibitor, both in late-stage development.
GlaxoSmithKline (GSK) has joined with University of North Carolina at Chapel Hill to pursue HIV cure strategies.
Pharma giant GlaxoSmithKline (GSK) might plan an initial public offering (IPO) of a minority stake in ViiV Healthcare, which makes new HIV med...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.